Dr. Stahl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2525 S Downing St
Denver, CO 80210Phone+1 303-788-1955
Summary
- Dr. John Stahl is a radiation oncologist in Denver, CO. He received his medical degree from the University of Florida College of Medicine and has been in practice for more than 4 years. He is experienced in general radiation oncology, stereotactic radiosurgery, and stereotactic body radiotherapy. He has more than 20 publications and over 450 citings.
Education & Training
- Yale-New Haven Medical CenterResidency, Radiation Oncology, 2014 - 2018
- University of Florida College of Medicine2009-2013 M.D., Cum Laude
- Vanderbilt UniversityBA, Molecular and Cellular Biology, Summa Cum Laude, 2005 - 2009
Certifications & Licensure
- CO State Medical License 2022 - 2025
- AL State Medical License 2018 - 2022
- CT State Medical License 2015 - 2018
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Roentgen Resident/Fellow Research Award RSNA, 2018
Publications & Presentations
PubMed
- 61 citationsIncrease in PD-L1 expression after pre-operative radiotherapy for soft tissue sarcoma.Kirtesh R. Patel, Anthony P. Martinez, John M. Stahl, Suzanna J. Logan, Adam J Perricone
Oncoimmunology. 2018-03-15 - 13 citationsThe impact of cobalt-60 source age on biologically effective dose in high-dose functional Gamma Knife radiosurgeryBenjamin H. Kann, James B. Yu, John M. Stahl, James E. Bond, Christopher Loiselle
Journal of Neurosurgery. 2016-12-01 - 69 citationsMulti-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors.Vivek Verma, Valerie Shostrom, Sameera S. Kumar, Weining Zhen, Christopher L. Hallemeier
Cancer. 2017-02-15
Press Mentions
- Yale Researchers Identify Optimal Therapy for Patients with Early-Stage Glottic Cancer (Vocal Chord Cancer)April 26th, 2017
Professional Memberships
- Member
- American Society for Radiation Oncology (ASTRO)Member
- American Radium Society (ARS)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: